Expert consensus on infection prevention and control of Creutzfeldt-Jakob disease in medical institutions
- VernacularTitle:克-雅病医疗机构感染防控专家共识
- Author:
Tianxiang GE
1
;
Yangyang JIA
;
Chunhui LI
;
Jianrong HUANG
;
Xiujuan MENG
;
Xiaodong GAO
;
Jingping ZHANG
;
Fu QIAO
;
Lijuan XIONG
;
Hui LIANG
;
Wei LI
;
Haiyan LOU
;
Wenjuan WU
;
Tianxin XIANG
;
Jiansen CHEN
;
Biao ZHU
;
Kaijin XU
;
Zhihui ZHOU
;
Hongliu CAI
;
Meihong YU
;
Yan ZHANG
;
Yanwan SHANGGUAN
;
Haiting FENG
;
Hangping YAO
;
Lei GUO
;
Tieer GAN
;
Weihong ZHANG
;
Jimin SUN
;
Ye LU
;
Qun LU
;
Meng CAI
;
Jin SHEN
;
Yunsong YU
;
Anhua WU
;
Liu-yi LI
;
Tingting QU
Author Information
- Publication Type:Journal Article
- Keywords: Creutzfeldt-Jakob disease; prion; healthcare-associated infection prevention and control; expert con-sensus
- From: Chinese Journal of Infection Control 2025;24(4):437-450
- CountryChina
- Language:Chinese
- Abstract: Creutzfeldt-Jakob disease(CJD)is a rapidly progressive and fatal neurodegenerative disorder caused by prions,with certain infectivity and iatrogenic transmission risks.With the rapid progress and application of new dia-gnostic biomarkers and detection methods,as well as the construction and improvement of surveillance and reporting systems,the detection of CJD in patients domestically and internationally has shown an increasing trend year by year.Due to its long incubation period and heterogeneity of early symptoms,early identification and diagnosis of the disease is difficult,increasing the risk of transmission within medical institutions.Currently,there is a lack of con-sensus on the infection prevention and control of CJD.In order to timely identify and diagnose CJD as well as effec-tively block its transmission in medical institutions,this consensus summarizes 15 clinical concerns and formulates 24 specific recommendations based on the latest domestic and international research findings and clinical evidence,as well as combines with clinical practice,aiming to standardize healthcare-associated infection prevention and control measures for CJD and reduce its transmission risk in medical institutions.
